Teva Pharmaceuticals USA, Inc. Recall: Terazosin Hydrochloride Capsules, 2 mg, packaged in
Teva Pharmaceuticals USA, Inc. Recall: Terazosin Hydrochloride Capsules, 2 mg, packaged in is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Teva Pharmaceuticals USA, Inc.; Product: Terazosin Hydrochloride Capsules, 2 mg, packaged in a) 100-count bottles (NDC 0093-4337-01); and b) 1000-c
| Recalling firm | Teva Pharmaceuticals USA, Inc. |
|---|---|
| Product | Terazosin Hydrochloride Capsules, 2 mg, packaged in a) 100-count bottles (NDC 0093-4337-01); and b) 1000-count bottles (NDC 0093-4337-10), Rx only, Manufactured in India By: Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat, India - 382 210; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960. |
| Reason for recall | Presence of Foreign Tablets/Capsules: Recall is being conducted due to a foreign capsule found in one bottle. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide |
| Recall initiated | 20130123 |
| Recall number | D-193-2013 |
| Category | drug |
| State | PA |
| Country | United States |
$29/mo
Try RecallGuard →